USD614303S1 - Eye treatment apparatus - Google Patents

Eye treatment apparatus Download PDF

Info

Publication number
USD614303S1
USD614303S1 US29/303,314 US30331408F USD614303S US D614303 S1 USD614303 S1 US D614303S1 US 30331408 F US30331408 F US 30331408F US D614303 S USD614303 S US D614303S
Authority
US
United States
Prior art keywords
treatment apparatus
eye treatment
eye
view
ornamental design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/303,314
Inventor
Keith H. Gausmann
Stephen M. Grenon
Julia Rose Anderson
David Chesley
Gary Prokop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HERBST LAZAR BELL Inc
TearScience Inc
Original Assignee
TearScience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TearScience Inc filed Critical TearScience Inc
Priority to US29/303,314 priority Critical patent/USD614303S1/en
Assigned to HERBST LAZAR BELL INC. reassignment HERBST LAZAR BELL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ANDERSON, JULIA ROSE, PROKOP, GARY, CHESLEY, DAVID
Assigned to KOLIS SCIENTIFIC, INC. reassignment KOLIS SCIENTIFIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HERBST LAZAR BELL INC.
Assigned to KOLIS SCIENTIFIC, INC. reassignment KOLIS SCIENTIFIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GAUSMANN, KEITH H., GRENON, STEPHEN M.
Assigned to TEARSCIENCE, INC. reassignment TEARSCIENCE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: KOLIS SCIENTIFIC, INC.
Application granted granted Critical
Publication of USD614303S1 publication Critical patent/USD614303S1/en
Assigned to HEALTHCARE ROYALTY PARTNERS II, L.P. reassignment HEALTHCARE ROYALTY PARTNERS II, L.P. SECURITY AGREEMENT Assignors: TEARSCIENCE, INC.
Assigned to TEARSCIENCE, INC. reassignment TEARSCIENCE, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: HEALTHCARE ROYALTY PARTNERS II, L.P.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a perspective view of an eye treatment apparatus according to the present invention;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a left side view thereof;
FIG. 5 is a right side view thereof;
FIG. 6 is a top view thereof; and,
FIG. 7 is a bottom view thereof.
The broken line showing a portion of an eye treatment apparatus is included for illustrating environmental structure and forms no part of the claimed design.

Claims (1)

  1. The ornamental design for eye treatment apparatus, as shown and described.
US29/303,314 2008-02-06 2008-02-06 Eye treatment apparatus Expired - Lifetime USD614303S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/303,314 USD614303S1 (en) 2008-02-06 2008-02-06 Eye treatment apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/303,314 USD614303S1 (en) 2008-02-06 2008-02-06 Eye treatment apparatus

Publications (1)

Publication Number Publication Date
USD614303S1 true USD614303S1 (en) 2010-04-20

Family

ID=42103778

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/303,314 Expired - Lifetime USD614303S1 (en) 2008-02-06 2008-02-06 Eye treatment apparatus

Country Status (1)

Country Link
US (1) USD614303S1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486031B2 (en) 2011-07-29 2013-07-16 Allan J. Bogdan Eye treatment apparatus
US8918181B2 (en) 2010-11-16 2014-12-23 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US8996137B2 (en) 2013-04-19 2015-03-31 Oculeve, Inc. Nasal stimulation devices and methods
USD736927S1 (en) * 2011-10-18 2015-08-18 Oasis Medical, Inc. Ophthalmic structure
US9265956B2 (en) 2013-03-08 2016-02-23 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9510972B2 (en) 2012-01-04 2016-12-06 Sight Sciences, Inc. Dry eye treatment systems
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
US9724230B2 (en) 2012-01-04 2017-08-08 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US9764150B2 (en) 2014-10-22 2017-09-19 Oculeve, Inc. Contact lens for increasing tear production
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
USD863390S1 (en) * 2013-05-17 2019-10-15 Johnson & Johnson Vision Care, Inc. Ophthalmic lens
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10973680B2 (en) 2012-01-04 2021-04-13 Sight Sciences, Inc. Controller for dry eye treatment systems
US11285040B2 (en) 2012-01-04 2022-03-29 Sight Sciences, Inc. Combination treatment systems
USD958997S1 (en) * 2019-11-21 2022-07-26 Maxell, Ltd. Swallowing sensor

Non-Patent Citations (27)

* Cited by examiner, † Cited by third party
Title
"arGentis Licenses Third Treatment for Dry Eye Syndrome" www.businesswire.com, May 12, 2008.
"New Over-the-Counter Dry Eye Drop Now Available to Help Estimated 40 Percent of Americans Who Suffer from Occasional or Chronic Dry Eye" Business Wire News Release, Published Mar. 31, 2008.
Aronowicz, J D et al. "Short Term Oral Minocycline Treatment of Meibomiantis" Br. J Opthalmol, vol. 90, No. 7, Jul. 2006.
Blackie, Caroline A. et al., "Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology," Optometry and Vision Science, vol. 85, No. 8, Aug. 2008, pp. 675-683.
Blackie, Caroline A. et al., "Recovery Time of an Optimally Secreting Meibomian Gland," Cornea, vol. 28, No. 3, Apr. 2009, pp. 293-297.
Goto, E. et al, "Treatment of Non-Inflamed Obstructive Meibomian Gland Dysfunction by an Infrared Warm Compression Device" Br J Opthalmol, vol. 86, No. 12, Dec. 2002.
Goto, E., et al. "Treatment of Non-Inflamed Obstructive Meibomian Gland Dysfunction by an Infrared Warm Compression Device" British Journal of Ophthalmology, BJO Online, http://www.bmjjournals.com/cgi/reprintform, vol. 26, 2002, 6 pages (pp. 1402-1407).
Goto, Eiki, et al., "Tear Evaporation Dynamics in Normal Subjects and Subjects with Obstructive Meibomian Gland Dysfunction," Investigative Ophthalmology & Visual Science, vol. 44, No. 2, Feb. 2003, 7 pages (pp. 533-539)
Gupta, S. et al. "Docetaxel-induced Meibomian Duct Inflammation and Blockage Leading to Chalazion Formation"Prostate Cancer Prostatic Diseases, vol. 10, No. 4, 2007.
Kokke, K.H. et al., "Oral Omega-6 Essential Fatty Acid Treatment in Contact Lens Associated Dry Eye," Contact Lens and Anterior Eye, vol. 31, No. 3, 2008, pp. 141-146.
Korb, Donald R. et al., "Increase in Tear Film Lipid Layer Thickness Following Treatment of Meibomian Gland Dysfunction" Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science Clinical Relevance. Adv. Exp. Med. Biol., vol. 350, 1994, 6 pages (pp. 293-298).
Korb, Donald R. et al., Slide entitled "Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology," from presentation entitled "The Greatest Anterior Segment Disease and Contacet Lens Complications Course," AOA Meeting, Seattle, Washington, Jun. 27, 2008, 2 pages.
Korb, Donald R., O.D., et al., "Meibomian Gland Dysfunction and Contact Lens Intolerance" Jnl American Optometric Association, vol. 51, No. 3, Mar. 1980, 9 pages (pp. 243-251).
Korb, Donald R., Slide entitled "Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology," from presentation entitled "The Tear Film and Dry Eye States A Fertile Research Area," University of California at Berkeley, School of Optometry, Apr. 11, 2008, 2 pages.
Kuscu, Naci Kemal, et al., "Tear Function Changes of Postmenopausal Women in Response to Hormone Replacement Therapy," Maturitas 44, 63-68, 2003, 6 pages.
Lemp, Michael A., et al., "The Therapeutic Role of Lipids—Managing Ocular Surface Disease," Refractive Eyecare for Ophthalmologists, vol. 9, No. 6, Jun. 2005, 14 pages.
Minco "Introducing: Thermofoil Heaters" Bulletin HS-202, 9 pages.
Mitra, M. et al., "Tear Film Lipid Layer Thickness and Ocular Comfort after Meibomian Therapy via Latent Heat with a Novel Device in Normal Subjects" Eye, vol. 19, 2005, 4 pages (p. 657-660).
Mori, A., et al., "Efficacy of the Treatment by the Disposable Eyelid Warming Instrument for Meibomian Gland Dysfunction," Poster Presentation, Hall A, 1 page.
Mori, Asako, et al., "Disposable Eyelid-Warming Device for the Treatment of Meibomian Gland Dysfunction," Jpn J Ophthalmol, vol. 47: 578-586, 2003, 9 page (pp. 578-586).
Olson, Mary Catherine, B.A., et al., "Increase in Tear Film Lipid Layer Thickness Following Treatment with Warm Compresses in Patients with Meibomian Gland Dysfunction" Eye & Contact Lens, vol. 29(2), 2003, 6 pages.
Paugh, J.R. et al., "Meibomian Therapy in Problematic Contact Lens Wear," Entrez PubMed, Optom Vis Sci. Nov. 1990; 68(11): 803-6, 1 page.
Romero, Juan M., et al., "Conservative Treatment of Meibomian Gland Dysfunction," Eye and Contact Lens, vol. 30, No. 1, 2004, 6 pages (pp. 14-19).
Sullivan, Benjamin D., et al., "Impact of Antiandrogen Treatment on the Fatty Acid Profile of Neutral Lipids in Human Meibomian Gland Secretions," The Journal of Clinical Endocrinology & Metabolism, vol. 85, No. 12, 2000, 8 pages (pp. 4866-4873).
Tobler, David et al., "Nanotech Silver Fights Microbes in Medical Devices," ND & DI, devicelink.com, 1 page.
Unknown, "Anatomy of the Eye and Orbit," p. 170.
Unknown, "IFU Manual for PNT Model 1000—Rev H," 24 pages.

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835748B2 (en) 2010-11-16 2020-11-17 Oculeve, Inc. Stimulation devices and methods
US8918181B2 (en) 2010-11-16 2014-12-23 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US11771908B2 (en) 2010-11-16 2023-10-03 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US9095723B2 (en) 2010-11-16 2015-08-04 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10143846B2 (en) 2010-11-16 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10328262B2 (en) 2010-11-16 2019-06-25 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10722718B2 (en) 2010-11-16 2020-07-28 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US9192513B2 (en) 2011-07-29 2015-11-24 Allan J. Bogdan Eye treatement apparatus
US8486031B2 (en) 2011-07-29 2013-07-16 Allan J. Bogdan Eye treatment apparatus
USD736927S1 (en) * 2011-10-18 2015-08-18 Oasis Medical, Inc. Ophthalmic structure
USD739021S1 (en) * 2011-10-18 2015-09-15 Oasis Medical, Inc. Ophthalmic structure
US11285040B2 (en) 2012-01-04 2022-03-29 Sight Sciences, Inc. Combination treatment systems
US9724230B2 (en) 2012-01-04 2017-08-08 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US10925765B2 (en) 2012-01-04 2021-02-23 Sight Sciences, Inc. Dry eye treatment systems
US9510972B2 (en) 2012-01-04 2016-12-06 Sight Sciences, Inc. Dry eye treatment systems
US10772758B2 (en) 2012-01-04 2020-09-15 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US9844459B2 (en) 2012-01-04 2017-12-19 Sight Sciences, Inc. Dry eye treatment systems
US10052226B2 (en) 2012-01-04 2018-08-21 Sight Sciences, Inc. Dry eye treatment systems
US10973680B2 (en) 2012-01-04 2021-04-13 Sight Sciences, Inc. Controller for dry eye treatment systems
US9642743B2 (en) 2012-01-04 2017-05-09 Sight Sciences, Inc. Methods for improving contact lens comfort
US9265956B2 (en) 2013-03-08 2016-02-23 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
US10537469B2 (en) 2013-03-12 2020-01-21 Oculeve, Inc. Implant delivery devices, systems, and methods
US10155108B2 (en) 2013-04-19 2018-12-18 Oculeve, Inc. Nasal stimulation devices and methods
US10835738B2 (en) 2013-04-19 2020-11-17 Oculeve, Inc. Nasal stimulation devices and methods
US10238861B2 (en) 2013-04-19 2019-03-26 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
US8996137B2 (en) 2013-04-19 2015-03-31 Oculeve, Inc. Nasal stimulation devices and methods
US9440065B2 (en) 2013-04-19 2016-09-13 Oculeve, Inc. Nasal stimulation devices and methods
US10799695B2 (en) 2013-04-19 2020-10-13 Oculeve, Inc. Nasal stimulation devices and methods
US9737702B2 (en) 2013-04-19 2017-08-22 Oculeve, Inc. Nasal stimulation devices and methods
US10967173B2 (en) 2013-04-19 2021-04-06 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
USD863390S1 (en) * 2013-05-17 2019-10-15 Johnson & Johnson Vision Care, Inc. Ophthalmic lens
US9956397B2 (en) 2014-02-25 2018-05-01 Oculeve, Inc. Polymer Formulations for nasolacrimal stimulation
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10799696B2 (en) 2014-02-25 2020-10-13 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10722713B2 (en) 2014-07-25 2020-07-28 Oculeve, Inc. Stimulation patterns for treating dry eye
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
US10780273B2 (en) 2014-10-22 2020-09-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US9764150B2 (en) 2014-10-22 2017-09-19 Oculeve, Inc. Contact lens for increasing tear production
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10610695B2 (en) 2014-10-22 2020-04-07 Oculeve, Inc. Implantable device for increasing tear production
US10112048B2 (en) 2014-10-22 2018-10-30 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10940310B2 (en) 2016-02-19 2021-03-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
USD958997S1 (en) * 2019-11-21 2022-07-26 Maxell, Ltd. Swallowing sensor

Similar Documents

Publication Publication Date Title
USD614303S1 (en) Eye treatment apparatus
USD617443S1 (en) Eye treatment goggles
USD613408S1 (en) Eye treatment head gear
USD608817S1 (en) Spectacles
USD622757S1 (en) Spectacles
USD599840S1 (en) Eyewear
USD606113S1 (en) Eyewear
USD632783S1 (en) Connector for medical device
USD608496S1 (en) Lamp stand
USD620394S1 (en) Vehicle
USD593236S1 (en) Worklamp
USD603540S1 (en) Spotlight
USD638176S1 (en) Harness
USD585580S1 (en) Luminaire
USD619031S1 (en) Pendant
USD588746S1 (en) Pair of tweezers
USD607403S1 (en) Charger
USD582391S1 (en) Speaker
USD637253S1 (en) Waterslide
USD621194S1 (en) Massage cushion
USD608353S1 (en) Inline microphone for earphone
USD603968S1 (en) Stimulator
USD619709S1 (en) Endoscope
USD638876S1 (en) Eyewear
USD625640S1 (en) Ornament

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY